Dr. Ye Chen-Izu's lab at UC Davis focuses on understanding how mechanical forces affect the heart's function and its diseases. The lab investigates how heart muscle cells communicate with each other during contractions, particularly under stress from mechanical loading. By learning how these mechanisms work, the research aims to identify new treatments for heart conditions such as arrhythmias and heart failure, especially those triggered by high blood pressure.

Dr. Yoon Yeo's lab focuses on developing innovative drug delivery systems to treat eye diseases that cause blindness. They are particularly interested in repurposing the old antifungal drug griseofulvin to create long-acting formulations that can be injected into the eye for treating conditions like age-related macular degeneration. By using new polymer-based delivery methods, the lab aims to improve patient outcomes and convenience while reducing the cost of treatment.

Dr. Yeong Shin Yim's lab at the University of Pennsylvania focuses on how maternal immune responses during pregnancy affect brain development, specifically looking at differences between males and females. Their research investigates a specific signaling pathway (CXCR7/CXCL12) that is linked to neurodevelopmental disorders like autism and schizophrenia. By understanding these differences, the lab aims to uncover new ways to address and potentially prevent issues related to brain development that are influenced by maternal health.

Dr. Yonghao Yu's lab focuses on studying a specific protein modification called poly-ADP-ribosylation, which plays a critical role in how cells respond to stress and may be linked to neurodegenerative diseases like ALS and frontotemporal dementia. By using advanced techniques in mass spectrometry and bioinformatics, the lab aims to understand how this modification contributes to disease processes and potentially identify new therapeutic targets for treatment.

Dr. Tony Yuen's lab at the Icahn School of Medicine focuses on understanding how certain hormones affect brain health, particularly in relation to Alzheimer's disease in postmenopausal women. They are developing new tools to target and study the role of a hormone called follicle-stimulating hormone (FSH) in the brain, and how reducing its receptor can help alleviate memory loss and other cognitive issues associated with aging. Their research combines advanced genetic techniques and innovative viral delivery methods to explore potential treatments for these conditions.

Dr. Xuewu Zhang's lab at UT Southwestern Medical Center focuses on studying the STING protein, which is crucial for the body's defense against viruses and cancer. The lab works to uncover how STING is regulated and aims to develop new drugs that activate STING to enhance immune responses. This research could lead to innovative treatments for cancer and viral infections.

The lab led by Dr. Li Zhang focuses on understanding the role of a specific protein, integrin CD11b, in the regression of atherosclerosis, a condition that causes artery hardening and narrowing, leading to cardiovascular diseases. Their research aims to develop new therapeutic strategies to promote the regression of atherosclerotic plaques by investigating the interactions between CD11b, cholesterol transport proteins, and inflammation in macrophages. This work is important for designing more effective treatments that could lower healthcare costs associated with cardiovascular diseases.

Dr. Yong Zhang's lab at USC focuses on innovating therapies for triple negative breast cancer (TNBC), a challenging and aggressive form of cancer. They are developing engineered exosomes—small vesicles that can boost immune responses to target TNBC tumors. The research aims to create safer and more effective treatments, potentially transforming how TNBC is managed in clinical settings.

Dr. Jin Zhang's lab at UC San Diego focuses on understanding the complex signaling pathways in cells, particularly how they regulate crucial processes like growth and metabolism. The research explores the mechanisms behind cancer cell behavior and the role of specific proteins, such as cyclic AMP and protein kinases, in controlling these processes. By developing innovative imaging technologies and biosensors, the lab aims to uncover how disruptions in these signaling pathways contribute to diseases like cancer and diabetes, with the goal of sparking new therapeutic approaches.

Dr. Qi Zhou's lab focuses on improving treatments for serious lung infections caused by multidrug-resistant bacteria, known as 'superbugs.' They are developing more effective ways to deliver antibiotics directly to the lungs using innovative aerosol systems, while minimizing side effects and preventing bacteria from becoming resistant. Their work combines advanced technologies like imaging and machine learning with pharmacological research to enhance patient outcomes in pulmonary medicine.

Dr. Ming-Ming Zhou's lab focuses on understanding how certain immune cells, specifically a type of T helper cell known as Th2 cells, develop and function in relation to diseases like asthma and allergies. By studying the mechanisms that control gene expression in these cells, the lab aims to uncover new targets for therapies that can better manage and potentially cure allergic diseases.

Dr. Guizhi Zhu's lab at the University of Michigan focuses on developing advanced vaccines for treating melanoma, a severe form of skin cancer. The lab is innovating small circular mRNA vaccines that enhance immune responses against tumors. Their aim is to improve the effectiveness of existing melanoma immunotherapies by providing a longer-lasting and more robust immune reaction to cancer cells.

Dr. Larry S. Zweifel's lab at the University of Washington focuses on how our emotions, especially positive and negative feelings, interact in the brain to affect learning and memory. By studying the central amygdala, a brain area involved in processing emotions, the lab aims to understand how positive stimuli can alter responses to fear and anxiety. This research has important implications for improving therapies for anxiety disorders, making them more effective in treating patients.